DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
75.24
+0.36 (0.48%)
At close: Nov 20, 2024, 4:00 PM
75.00
-0.24 (-0.32%)
After-hours: Nov 20, 2024, 7:59 PM EST

Company Description

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

The company provides its systems for use by people with diabetes, as well as for use by healthcare providers.

Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions.

It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products.

It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

DexCom, Inc.
DexCom logo
Country United States
Founded 1999
IPO Date Apr 14, 2005
Industry Medical Devices
Sector Healthcare
Employees 9,600
CEO Kevin Sayer

Contact Details

Address:
6340 Sequence Drive
San Diego, California 92121
United States
Phone 858 200 0200
Website dexcom.com

Stock Details

Ticker Symbol DXCM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001093557
CUSIP Number 252131107
ISIN Number US2521311074
Employer ID 33-0857544
SIC Code 3841

Key Executives

Name Position
Kevin Ronald Sayer Executive Chairman, Chief Executive Officer and President
Jacob Steven Leach Executive Vice President and Chief Operating Officer
Michael Jon Brown Executive Vice President and Chief Legal Officer
Teri Lawver Executive Vice President and Chief Commercial Officer
Girish Naganathan Executive Vice President and Chief Technology Officer
Sean Christensen Director of Corporate Affairs and Head of Investor Relations
Matthew Dolan Executive Vice President of Strategy, Corporate Development and Dexcom Labs
Leverne Marsh Executive Vice President of Marketing
Sadie M. Stern Executive Vice President and Chief Human Resources Officer
Donald M. Abbey Executive Vice President of Global Business Services, Quality and Regulatory Affairs

Latest SEC Filings

Date Type Title
Nov 15, 2024 144 Filing
Oct 24, 2024 10-Q Quarterly Report
Oct 24, 2024 8-K Current Report
Sep 16, 2024 144 Filing
Aug 30, 2024 144 Filing
Jul 31, 2024 144 Filing
Jul 25, 2024 10-Q Quarterly Report
Jul 25, 2024 8-K Current Report
Jun 28, 2024 144 Filing
Jun 18, 2024 144 Filing